Newsroom

News

Prof Rolf Müller, the Founding and Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Bioltechnology at Saarland University, has been honoured with the prestigious Charles Thom Award. This award, given by the Society for Industrial Microbiology and Biotechnology (SIMB) and named after industrial microbiology and mycology pioneer Charles Thom, honours researchers for their exceptional merit in industrial microbiology and biotechnology, and their independence of thought and originality that added appreciably to scientific knowledge. The HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

07.08.2023

HIPS

News

Mecklenburg-Western Pomerania's Minister of Science, Bettina Martin, announced today (July 31, 2023) in Greifswald 15 million euros of additional state funding for the construction of the Helmholtz Institute for One Health (HIOH). In the interim laboratories of the HIOH, in the presence of the Rector of the University of Greifswald, Prof Katharina Riedel, and the founding director of the Helmholtz Institute for One Health, Prof Fabian Leendertz, she informed about the extended state funding for the new construction of the research center.

31.07.2023

HIOH

Helicobacter pylori, a pathogen residing in the stomach, is the cause of the most common chronic bacterial infection. ©HZI/Rohde

News

The constant rise in antimicrobial resistance (AMR) has a major impact on global public health, urgently requiring novel strategies to prevent and treat bacterial infections. The development of effective vaccines represents an attractive cost-effective alternative to novel antibiotics and would be a game changer for patients. For many bacterial infections, especially those occurring on mucosal sites, no effective vaccines exist. Helicobacter pylori (H. pylori), a pathogen residing in the stomach, is the cause of the most common chronic bacterial infection, affecting half of the world´s population, with a high risk to progress into gastric cancer. Therefore, among other gastrointestinal pathogens, H. pylori was declared as priority neglected AMR target pathogen by the WHO, requiring rapid intervention to counter AMR. Standard-of-care for H. pylori is still an antibiotic therapy combined with a proton pump inhibitor, and thus effective treatment of H. pylori infection is severely hampered by rising AMR.

24.07.2023

HZI Campus

News

The Else Kröner-Fresenius Foundation's ForTra gGmbH for Research Transfer—the largest medicine-funding foundation in Germany—supports the legally compliant production of new drug candidates for direct use in first-in-human clinical trials. Five projects—including two antimicrobial drug discovery projects of the German Center for Infection Research (DZIF)—are now being funded with a total of three million euros. One of the funded drug candidates was discovered and co-developed at the Helmholtz Centre for Infection Research (HZI) in Braunschweig.

19.07.2023

HZI Campus

News

In his doctoral thesis at the Helmholtz Institute for RNA-based Infection Research (HIRI), Chunlei Jiao has paved the way for the development of the CRISPR-based RNA detection and recording platforms known as LEOPARD and TIGER. LEOPARD is a CRISPR-based method that is highly multiplexable, with the potential to detect a variety of disease-related biomarkers in just one test. On the other hand, TIGER enables the recording of transient cellular events at the single-cell level. The Helmholtz Association honors this outstanding achievement with the Doctoral Prize in the research field Health. The HIRI is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig in cooperation with the Julius-Maximilians-Universität (JMU) Würzburg.

17.07.2023

HIRI

News

With numerous supporters, cooperation partners and companions, the Helmholtz Institute for RNA-based Infection Research (HIRI) Würzburg celebrated its groundbreaking ceremony today, July 6. The institute, a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) founded in 2017 in cooperation with the Julius-Maximilians-Universität (JMU) in the city on the River Main, will have its own building on the Würzburg medical campus. The project is being realized with funds from the Free State of Bavaria, represented by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy, and co-financed by the European Union.In his festive speech, Bavaria's Minister President Markus Söder emphasized the relevance of research funding for the Free State's strategy for the future.

06.07.2023

HIRI

Back to the first page
...
31
32
33
34
...
147

HZI in the media

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025

Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025

Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025

Apotheken Umschau

... am 1. Oktober 2025. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

07.10.2025

juraforum.de

... „Epidemiologie und Ökologie antimikrobieller Resistenz“ am HZI-Standort Helmholtz-Institut für One Health (HIOH), am Projekt ...

06.10.2025

Bochumer-Zeitung

” says Mark Brönstrup, a professor at both the Helmholtz Center for Infection Research and Leibniz University Hannover, who wasn’t involved

04.10.2025

MIT CSAIL

... Hannover (MHH) und Klinischer Direktor des Helmholtz-Zentrums für Infektionsforschung (HZI). Auch an der Gründung des ...

03.10.2025

Deutsches Ärzteblatt

... des Sensormoleküls

Prof. Carlos A. Guzmán (Helmholtz-Zentrum für Infektionsforschung, Braunschweig) mit den Teams um Dr. ...

02.10.2025

Medizin Aspekte

... ” Seit Mai 2025 im Humanprogramm des Helmholtz-Zentrums für Infektionsforschung (HZI), Dr. Max Kellner-Leiter der jungen ...

25.09.2025

Die heutigen Nachrichten

” (Vico) within the Human program at the Helmholtz Centre for Infection Research (HZI).the‌ Vico group continues to investigate resilience

25.09.2025

World Today News

Forschende des Helmholtz-Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für ...

19.09.2025

Verband Deutscher Biologen e.V.

purposes.

Researchers at the HIRI, a site of the Braunschweig Helmholtz Center for Infection Research (HZI), in cooperation with the Julius

19.09.2025

NewsBreak

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.